Sympathectomy for Lymphedema: A Case Series
- PMID: 33623320
- PMCID: PMC7888422
- DOI: 10.4103/IJPC.IJPC_36_20
Sympathectomy for Lymphedema: A Case Series
Abstract
Breast cancer-related lymphedema (BCRL) is an increasingly common complication seen in the palliative care setting due to increased life expectancy of breast cancer survivors. It is an important determinant of the quality of life of breast cancer survivors, due to the functional impact that it has, apart from the pain and deformity associated with it. Conservative management of lymphedema with the help of physiotherapy, positioning, manual lymphatic drainage, and intermittent pneumatic compression is well known. Even then, there remains a subset of patients that fail to respond to conservative management. T2 sympathectomy is a technique which ablates the thoracic sympathetic chain and helps in improving the lymphatic drainage. We report a series of four cases of BCRL, which showed a significant reduction in the mid-arm circumference as well as pain scores after a T2 sympathectomy. We believe that T2 sympathectomy can be used as the second line of management in lymphedema patients in whom conservative treatment has failed.
Keywords: Breast cancer-related lymphedema; T2 sympathectomy; lymphedema; sympathectomy.
Copyright: © 2020 Indian Journal of Palliative Care.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Sympathetic Block as a New Treatment for Lymphedema.Pain Physician. 2015 Jul-Aug;18(4):365-72. Pain Physician. 2015. PMID: 26218940
-
Bilateral Changes in Deep Tissue Environment After Manual Lymphatic Drainage in Patients with Breast Cancer Treatment-Related Lymphedema.Lymphat Res Biol. 2017 Mar;15(1):45-56. doi: 10.1089/lrb.2016.0020. Lymphat Res Biol. 2017. PMID: 28323572 Free PMC article.
-
The efficacy of intermittent pneumatic compression as a substitute for manual lymphatic drainage in complete decongestive therapy in the treatment of breast cancer related lymphedema.Lymphology. 2019;52(2):82-91. Lymphology. 2019. PMID: 31525829 Clinical Trial.
-
A Review of Treatment for Breast Cancer-Related Lymphedema: Paradigms for Clinical Practice.Am J Clin Oncol. 2018 Feb;41(2):178-190. doi: 10.1097/COC.0000000000000355. Am J Clin Oncol. 2018. PMID: 28009597
-
Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.Gland Surg. 2018 Aug;7(4):379-403. doi: 10.21037/gs.2017.11.04. Gland Surg. 2018. PMID: 30175055 Free PMC article. Review.
References
-
- Ghoncheh M, Momenimovahed Z, Salehiniya H. Epidemiology, incidence and mortality of breast cancer in Asia. Asian Pac J Cancer Prev. 2016;17:47–52. - PubMed
-
- Manandhar S, Shrestha DS, Taechaboonsermsk P, Siri S, Suparp J. Quality of life among breast cancer patients undergoing treatment in national cancer centers in Nepal. Asian Pac J Cancer Prev. 2014;15:9753–7. - PubMed
-
- International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology. 2013;46:1–11. - PubMed
-
- Choi E, Nahm FS, Lee PB. Sympathetic block as a new treatment for lymphedema. Pain Physician. 2015;18:365–72. - PubMed
Publication types
LinkOut - more resources
Full Text Sources